ABOUT US Since its establishment in 2014, KMD Bioscience (Tianjin) Co., Ltd. has been committed to becoming a leading provider of drug antibody discovery, aptamer screening services, and related support. We focus on technology R&D, delivering high-quality CRO services to scientists and research institutions worldwide to advance pharmaceutical innovation. As a national patent pilot high-tech enterprise, we continuously expand our expertise and technical platforms to support global drug development.
Utility Model Patent Certificate9
Utility Model Patent Certificate21
Utility Model Patent Certificate20
Utility Model Patent Certificate18
Utility Model Patent Certificate17
Utility Model Patent Certificate16
Utility Model Patent Certificate15
Utility Model Patent Certificate14
Utility Model Patent Certificate13
Utility Model Patent Certificate12
Utility Model Patent Certificate11
Utility Model Patent Certificate10
Utility Model Patent Certificate8
Utility Model Patent Certificate7
Utility Model Patent Certificate6
Utility Model Patent Certificate5
Utility Model Patent Certificate4
Utility Model Patent Certificate3
Utility Model Patent Certificate2
Utility Model Patent Certificate1
Antigen screening quickly detects specific proteins to identify active infections providing rapid results for early...
Small molecule screening tests thousands of compounds to identify potential drugs that modulate a specific...
Aptamer Selection is the process of identifying synthetic DNA or RNA molecules (aptamers) that bind with high affinity and specificity to a target of interest, such as a protein...
Aptamer screening isolates specific nucleic acids that bind tightly to a target molecule, like proteins or cells, through an iterative selection process called SELEX.
Peptide Services Auburn Alabama – High-Quality Research Peptides from KMDbioscience.org Researchers, biotechnology companies, and academic laboratories in Auburn, Alabama increasingly depend on prec
Custom Peptides Auburn AL – Reliable China-Based Supplier Serving the USA Market Researchers and biotechnology companies in Auburn, Alabama increasingly depend on high-purity custom peptides for dru
Peptide Research Tuscaloosa: High-Purity Custom Peptide Solutions from a China-Based Supplier Serving the USA Peptide research continues to play a central role in biomedical innovation, drug discovery
Peptide Synthesis Services Mobile, USA – High-Purity Custom Peptides from China-Based Supplier KMDBioScience Introduction Researchers, biotech companies, and pharmaceutical developers in Mobile, Ala
Peptides Mobile Supplier for USA Laboratories – Quality from a China-Based Factory Peptides Mobile is becoming a preferred solution for research institutes, biotech companies, pharmaceutical develop
Leading Peptide Manufacturer Supplying Mobile, Alabama – High-Purity Peptides from KMDBioscience.org Researchers, biotech companies, pharmaceutical developers, and diagnostic laboratories in Mobile,
Custom Peptide Synthesis Montgomery – High-Purity Research Peptides from China-Based KMDBioscience Research institutions, biotechnology labs, and pharmaceutical developers in Montgomery, Alabama inc
Peptide Screening Montgomery: Advanced Research Solutions from China-Based Supplier KMD Bioscience Researchers and pharmaceutical innovators in Montgomery, Alabama increasingly rely on precise, data-d
Aptamer Selection is the process of identifying synthetic DNA or RNA molecules (aptamers) that bind with high affinity and specificity to a target of interest, such as a protein, small molecule, or cell. This is primarily achieved through an iterative laboratory technique called SELEX (Systematic Evolution of Ligands by EXponential enrichment), which enriches specific binding sequences from a vast random library over multiple rounds.
Get a Sample
Peptide-Drug Conjugates (PDCs) are targeted therapeutics that chemically link a biologically active drug (“payload”) to a peptide that guides the payload toward a specific receptor, microenvironment, or cellular compartment. Conceptually, PDCs resemble Antibody–Drug Conjugates (ADCs), but replace the antibody with a peptide, aiming to keep targeting precision while improving tissue penetration, manufacturing accessibility, and design flexibility. 1) What Exactly Is a PDC (and Why It Matters)? A typical PDC is built from three modular parts: Targeting peptide (the “homing” component) Linker (the chemical bridge that controls stability and payload release) Payload (cytotoxic drug, radionuclide, or other potent therapeutic)…
Venture capital interest in AI-driven drug discovery has moved from “promise” to a more disciplined phase of investment & funding. Capital is still available, but it increasingly concentrates in teams and platforms that can prove (1) credible biology, (2) proprietary data advantage, and (3) a realistic path to value creation—whether through licensing, partnerships, or clinical progression. Recent industry tracking highlights a rebound in AI funding within drug R&D and emphasizes that “discovery engines” have captured a significant share of investment attention. This article explains the category in a knowledge-first way: what investors look for, common funding structures, due diligence…
